Filed: 3/31/2022ACC: 0001104659-22-041138
Officer· EVP Clinical Development
Since Jun 2021
+213.30K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
213.30K acquired
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
213.30K shares
Shares
+213.30K
Strike price
8.13
Held after
213.30K
Exercisable
—
3/29/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock213.30K shares | 3/29/2022 | A · Award | +213.30K | 8.13 | — | 213.30K |